Dara Aisner, MD, PhD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AstraZeneca
    Topic:
    Advisory Board
    Date added:
    01/04/2023
    Date updated:
    01/04/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sanofi Genzyme
    Topic:
    Advisory Board
    Date added:
    01/04/2023
    Date updated:
    01/04/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Loxo/Eli Lilly
    Topic:
    Advisory Board
    Date added:
    01/04/2023
    Date updated:
    01/04/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genentech
    Topic:
    Advisory Board
    Date added:
    01/04/2023
    Date updated:
    01/04/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Abbvie
    Topic:
    Advisory Board
    Date added:
    01/04/2023
    Date updated:
    01/04/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Takeda
    Topic:
    Advisory Board
    Date added:
    01/04/2023
    Date updated:
    01/04/2023
Return to San Diego Multidisciplinary Thoracic Oncology Symposium: Patient-centered approach to improve outcomes